Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Saad Mark E | Sep 11, 2024 | Sell | 11,016 | $91.31 | $1M |
| Jacobson Mark L. | Aug 9, 2024 | Sell | 47,739 | $84.26 | $4M |
| Jacobson Mark L. | May 29, 2024 | Sell | 7,910 | $74.3127 | $590,000 |
| Coleman Mark | May 29, 2024 | Sell | 5,248 | $75.1396 | $390,000 |
| Coleman Mark | May 28, 2024 | Sell | 5,249 | $75.2095 | $390,000 |
| Jacobson Mark L. | Apr 1, 2024 | Sell | 24,662 | $77.242 | $1.9M |
| JEFFS ROGER | Mar 15, 2024 | Sell | 2,347 | $71.6072 | $170,000 |
| JEFFS ROGER | Mar 14, 2024 | Sell | 16,976 | $69.702 | $1.2M |
| JEFFS ROGER | Mar 14, 2024 | Sell | 13,000 | $69.702 | $910,000 |
| Coleman Mark | Sep 15, 2023 | Sell | 18,572 | $75.1771 | $1.4M |
| Coleman Mark | Sep 15, 2023 | Sell | 11,016 | $75.1853 | $830,000 |
What's the latest insider transaction for Axsome Therapeutics?
The most recent insider transaction for Axsome Therapeutics was conducted by Saad Mark E, who sold 11,016 shares on September 11, 2024 at a price of $91.31 per share.
Which insider has sold the most AXSM stock over the last two years?
Jacobson Mark L. has sold the most AXSM stock in the last 2 years, with a total value of $6.5M.
What is the total value of insider transactions for Axsome Therapeutics (AXSM) in the last 2 years?
The total value of insider transactions for Axsome Therapeutics in the last 2 years is negative, amounting to -$13M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Axsome Therapeutics' market confidence?
Over the last 2 years, insider transactions for Axsome Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
